메뉴 건너뛰기
Clinical Oncology
Volumn 18, Issue 9, 2006, Pages 719-720
The Incidence and Treatment Outcome after Radiotherapy for Brain Metastases in HER-2-positive Metastatic Breast Cancer Patients Treated with Trastuzumab
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRASTUZUMAB;
EID: 33749041258     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2006.07.006     Document Type: Letter
Times cited : (2)
References (7)
  • 1
    • 0034040110 scopus 로고    scopus 로고
    • Patterns of disease spread in metastatic breast carcinoma; influence of estrogen and progesterone receptor status
    • Maki D.D., and Grossman R.I. Patterns of disease spread in metastatic breast carcinoma; influence of estrogen and progesterone receptor status. Am J Neuroradiol 21 (2000) 1064-1066
    • (2000) Am J Neuroradiol , vol.21 , pp. 1064-1066
    • Maki, D.D.1    Grossman, R.I.2
  • 2
    • 26844503270 scopus 로고    scopus 로고
    • Trastuzumab after adjuvant chemotherapy in HER-2 positive breast cancer
    • Piccart-Gebhart M.J., Procter M., Leyland-Jones B., et al. Trastuzumab after adjuvant chemotherapy in HER-2 positive breast cancer. New Engl J Med 353 (2005) 1659-1672
    • (2005) New Engl J Med , vol.353 , pp. 1659-1672
    • Piccart-Gebhart, M.J.1    Procter, M.2    Leyland-Jones, B.3
  • 3
    • 26844536978 scopus 로고    scopus 로고
    • Trastuzumab plus adjuvant chemotherapy for operable HER-2 positive breast cancer
    • Romond E.H., Perez E.A., Bryant J., et al. Trastuzumab plus adjuvant chemotherapy for operable HER-2 positive breast cancer. New Engl J Med 353 (2005) 1673-1684
    • (2005) New Engl J Med , vol.353 , pp. 1673-1684
    • Romond, E.H.1    Perez, E.A.2    Bryant, J.3
  • 4
    • 0038010542 scopus 로고    scopus 로고
    • Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast cancer
    • Bendall C.J., Domcheck S.M., Burstein H.J., et al. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast cancer. Cancer 97 (2003) 2972-2977
    • (2003) Cancer , vol.97 , pp. 2972-2977
    • Bendall, C.J.1    Domcheck, S.M.2    Burstein, H.J.3
  • 5
    • 3543083922 scopus 로고    scopus 로고
    • The risk of central nervous system metastases in women who receive trastuzumab therapy in patients with breast carcinoma
    • Lai R., Dang C.T., Malkin M.G., et al. The risk of central nervous system metastases in women who receive trastuzumab therapy in patients with breast carcinoma. Cancer 101 (2004) 810-816
    • (2004) Cancer , vol.101 , pp. 810-816
    • Lai, R.1    Dang, C.T.2    Malkin, M.G.3
  • 6
    • 33749068233 scopus 로고    scopus 로고
    • A prognostic model to predict the risk of developing brain metastasis in patients treated with trastuzumab for HER-2 positive metastatic breast cancer
    • (S74)
    • Pansegrau G.K., Lohrisch C.A., Bajdik C.D., et al. A prognostic model to predict the risk of developing brain metastasis in patients treated with trastuzumab for HER-2 positive metastatic breast cancer. (S74). Breast Cancer Res Treat 82 suppl 1 (2003) 320
    • (2003) Breast Cancer Res Treat , vol.82 , Issue.SUPPL. 1 , pp. 320
    • Pansegrau, G.K.1    Lohrisch, C.A.2    Bajdik, C.D.3
  • 7
    • 0842284676 scopus 로고    scopus 로고
    • Increased brain metastasis detected in metastatic breast cancer patients receiving herceptin
    • (S357)
    • Lower E.E., Blau R., Bismayer J., et al. Increased brain metastasis detected in metastatic breast cancer patients receiving herceptin. (S357). Breast Cancer Res Treat 69 (2001) 271
    • (2001) Breast Cancer Res Treat , vol.69 , pp. 271
    • Lower, E.E.1    Blau, R.2    Bismayer, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.